Main Article Content

Dildar Ali Solangi
Naseem Aslam Chann
Allah Bachayo Rajar
Aneel Kapoor
Irshad Chandio
Ghulam Serwar Shaikh
Abdul Hameed Lanjwani
Vinay Kumar Jesrani


Iron overload, renal chemistry, transfusion, thalassemia.


Background: In order to investigate the demographic, hematological and renal failure variables that affect TDT patients in Hyderabad and adjacent regions, the current study was conducted. 

Methods:  A total of 142 individuals were interviewed throughout the research period, comprising 71 TDT patients and 71 control subjects (age and gender matched with no personal or family history of blood disorders). Serum ferritin, hepatitis C and B, blood groups, hematological parameters, complete blood count have been compared with control groups. 

Results: When comparing TDT patients to the control group, we discovered that their serum haemoglobin (HB), mean corpuscular value (MCV), or mean corpuscular hemoglobin (MCH). In contrast to male control participants, red blood cells (RBC), HB, HCT, and MCV were shown to be considerably increased (p<0.05) in male patients and dramatically decreased (p<0.05) in both genders. It is a significant serum creatinine level was noted high among 5-10 years and 11-15 years in comparison to all other age groups. the higher level of serum urea at the age of 4-10 years and non-significant variation (p>0.05) was found among all other age groups of TDT patients.

Conclusions: Transfusion-related blood abnormalities in TDT patients include iron excess and its repercussions, which include injury to the kidneys and spleen. TDT patients also frequently have hepatic viral infections. It is important for medical professionals to carefully monitor and treat patients in order to lessen their suffering and help them return to a balanced way of life. 

Abstract 40 | PDF Downloads 20


1. Whipple GH, and Bradford WL. Mediterranean disease-thalassemia (erythroblast anemia of Cooley): associated pigment abnormalities simulating hemochromatosis. The Journal of Pediatrics, (1936); 9: 279-311.
2. Olivieri NF. The β-thalassemia, New England journal of medicine. (1999); 341: 99-109.
3. Ghosh M, Basu K, Karmakar S, Biswas A, Sengupta M, CHATTERJEE U, et al. Thalassaemia Carrier Detection during Antenatal Period: Single Centre Experience from Eastern India. Journal of Clinical & Diagnostic Research. (2019); 13:12
4. Asif N, and Hassan K. Management of thalassemia in Pakistan. Journal of Islamabad Medical & Dental College. (2016); 5: 152-153.
5. Ghafoor MB. Level of awareness about thalassemia among parents of thalassaemic children. Journal of Rawalpindi Medical College. (2016); 20: 209-211.
6. Asif N. and Hassan K. Prevention of beta thalassemia in Pakistan. J Islam Med Dent Coll, (2014); 3:46-7.
7. Thein S L. Pathophysiology of β thalassemia—A guide to molecular therapies. ASH Education Program Book. (2005); 1:31-37.
8. Herbert L, Muncie J, James S, and Campbell M. Alpha and beta thalassemia. Am Fam Physician. (2009);. 80:339-44.
9. Galanello R, and Cao A. Alpha-thalassemia," Genetics in medicine. (2011);13:83-88.
10. Kutlar A, Gardiner M, Headlee M, Reese A, Cleek M, Nagle S, et al. Heterogeneity in the molecular basis of three types of hereditary persistence of fetal hemoglobin and the relative synthesis of the G γ and A γ types of γ chain. Biochemical genetics.(1984); 22:21-35.
11. Ngim C F, Lee MY, OthmanN, Lim SM, Ng CS, and Ramadas A. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia. Hemoglobin.(2019); 43: 95-100.
12. Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, et al. Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia. Diabetes, metabolic syndrome and obesity: targets and therapy.(2019);12:457.
13. Maheen H, Malik F, Siddique B, and Qidwai A. Assessing parental knowledge about thalassemia in a thalassemia center of Karachi, Pakistan. Journal of genetic counseling.(2015); 24:945-951, 2015.
14. Rudra S, Chakrabarty P, Hossain M, Ripon M, Rudra M, and Mirza T.Awareness among Parents of β-Thalassemia Major Patients Regarding Prenatal Diagnosis and Premarital Screening in Day Care Centre of Transfusion Medicine Department. Mymensingh medical journal: MMJ.(2016);25:12-17.
15. Hattab FN, Hazza’a AM, Yassin OM, and Al-Rimawi HS. Caries risk in patients with thalassaemia major. International dental journal.(2001); 51:35-38.
16. Yousafzai YM, Khan S, and Raziq F. β-thalassaemia trait: haematological parameters. Journal of Ayub Medical College Abbottabad(2010); 22: 84-86.
17. Ishaq F, Hasnain Abid F, Akhtar A, and Mahmood S.Awareness among parents of ββ-Thalassemia major patients, regarding prenatal diagnosis and premarital screening. Journal of the College of Physicians and Surgeons Pakistan. (2012); 22: 218-221.
18. Ishfaq K, Ahmad T, Naeem S, Ali J, and Zainab F. The knowledge of parents having thalassemia child. Isra Medical Journal.(2016); 8:79-81.
19. Ishfaq K, Shabbir M, Naeem SB, and Hussain S. Impact of Thalassemia major on patients. The Professional Medical Journal.(2015); 22:582-589.
20. Yaghobi R, Afkari R, Mohsenzadeh M, Jafari M, Khorrami H, and Pirouzi A. A study on the serologic and molecular prevalence of hepatitis G virus (HGV) and hepatitis C virus (HCV) infections in patients with thalassemia in Larestan of Iran. African Journal of Microbiology Research.(2012); 6:5866-5870.
21. Joly P, Pondarre C, and Badens C. Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects. In Annales de biologie clinique(2014);72: 639-668.
22. Lafferty JD, Barth DS, Sheridan BL, McFarlane AG, Halchuk LM, and Crowther MA. Prevalence of thalassemia in patients with microcytosis referred for hemoglobinopathy investigation in Ontario: a prospective cohort study. American journal of clinical pathology.(2007);127:192-196.
23. Langlois S, Ford JC, Chitayat D, Désilets VA, Farrell SA, Geraghty M, et al. Carrier screening for thalassemia and hemoglobinopathies in Canada. Journal of obstetrics and gynaecology Canada (2008); 30:950-959.
24. Mishra A K, and Tiwari A. Iron overload in beta thalassaemia major and intermedia patients," Maedica.(2013);8:328.
25. Ali D, Mehran K, and Moghaddam AG. Comparative evaluation of renal findings in Beta-thalassemia major and intermedia. Saudi journal of kidney diseases and transplantation. (2008);19:206.

Most read articles by the same author(s)